SEIPIN Regulates Lipid Droplet Expansion and Adipocyte Development by Modulating the Activity of Glycerol-3-phosphate Acyltransferase
0301 basic medicine
lipodystrophy
1300 Biochemistry
572
QH301-705.5
lipid droplets
610
Genetics and Molecular Biology
Saccharomyces cerevisiae
yeast
3101 Biochemistry and Cell Biology
Article
SEIPIN
adipogenesis
Mice
03 medical and health sciences
proteomics
GPAT3
GPAT4
3T3-L1 Cells
GTP-Binding Protein gamma Subunits
616
Adipocytes
2.1 Biological and endogenous factors
Animals
Humans
anzsrc-for: 31 Biological Sciences
Biology (General)
Enzyme Inhibitors
Mammals
0303 health sciences
Adipogenesis
anzsrc-for: 3101 Biochemistry and Cell Biology
Lipid Droplets
1-Acylglycerol-3-Phosphate O-Acyltransferase
Heterotrimeric GTP-Binding Proteins
AGPAT2
phosphatidic acid
Kinetics
BSCL
seipin
BSCL1
BSCL2
Drosophila
31 Biological Sciences
Protein Binding
DOI:
10.1016/j.celrep.2016.10.037
Publication Date:
2016-11-01T16:30:55Z
AUTHORS (21)
ABSTRACT
Berardinelli-Seip congenital lipodystrophy 2 (BSCL2) is caused by loss-of-function mutations in SEIPIN, a protein implicated in both adipogenesis and lipid droplet expansion but whose molecular function remains obscure. Here, we identify physical and functional interactions between SEIPIN and microsomal isoforms of glycerol-3-phosphate acyltransferase (GPAT) in multiple organisms. Compared to controls, GPAT activity was elevated in SEIPIN-deficient cells and tissues and GPAT kinetic values were altered. Increased GPAT activity appears to underpin the block in adipogenesis and abnormal lipid droplet morphology associated with SEIPIN loss. Overexpression of Gpat3 blocked adipogenesis, and Gpat3 knockdown in SEIPIN-deficient preadipocytes partially restored differentiation. GPAT overexpression in yeast, preadipocytes, and fly salivary glands also formed supersized lipid droplets. Finally, pharmacological inhibition of GPAT in Seipin-/- mouse preadipocytes partially restored adipogenesis. These data identify SEIPIN as an evolutionarily conserved regulator of microsomal GPAT and suggest that GPAT inhibitors might be useful for the treatment of human BSCL2 patients.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (52)
CITATIONS (148)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....